Select Page
<div style="position: relative; display: block; max-width: 100%;"><div style="padding-top: 56.25%;"><iframe src="//players.brightcove.net/4365621440001/216a41e4-093d-49b1-831c-dbf5b8ca99d9_default/index.html?videoId=6026854867001" <!-- [et_pb_line_break_holder] -->allowfullscreen <!-- [et_pb_line_break_holder] -->webkitallowfullscreen <!-- [et_pb_line_break_holder] -->mozallowfullscreen <!-- [et_pb_line_break_holder] -->allow="encrypted-media" <!-- [et_pb_line_break_holder] -->style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div></div><!-- [et_pb_line_break_holder] -->

Department of Medicine Grand Rounds
September 5, 2017

A Critical Review of Early Goal-Directed Therapy (EGDT) and Government Endorsement (SEP-1)

Charles Natanson, MD
Critical Care Medicine Department Clinical Center National Institutes of Health

View Presentation via BrightCove  |  CME Module